adoptive immunotherapy
liangping
Phase 3 mab completed
Quick answer
adoptive immunotherapy for Hepatocellular Carcinoma is a Phase 3 program (mab) at Chinese PLA General Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese PLA General Hospital
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 3
- Modality
- mab
- Status
- completed